Literature DB >> 32096127

Dermatomyositis: An Update on Diagnosis and Treatment.

Gabriela A Cobos1, Alisa Femia2, Ruth Ann Vleugels3.   

Abstract

Dermatomyositis is a rare inflammatory disease with characteristic cutaneous findings and varying amounts of systemic involvement. Patients may present with skin disease alone, have concomitant muscle disease, or have extracutaneous manifestations such as pulmonary disease or an associated malignancy. Given such diverse presentations, dermatomyositis is both a diagnostic and therapeutic challenge. However, a prompt diagnosis is of utmost importance to institute adequate therapy and screen patients for an associated malignancy. Dermatologists should play a crucial role in the diagnosis and management of patients with dermatomyositis as cutaneous disease tends to be chronic, negatively impact quality of life, and be more recalcitrant to therapy. In this review, we discuss diagnosis, with a focus on myositis-specific antibodies and their associated phenotypes. We also review therapies available for this often refractory skin disease.

Entities:  

Year:  2020        PMID: 32096127     DOI: 10.1007/s40257-020-00502-6

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  8 in total

1.  Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinib.

Authors:  Man Luo; Long Chen; Huan He; Fang He
Journal:  Eur J Med Res       Date:  2022-05-15       Impact factor: 4.981

2.  "Listen to Your Immune System When It's Calling for You": Monitoring Autoimmune Diseases Using the iShU App.

Authors:  Cláudia Ortet; Liliana Vale Costa
Journal:  Sensors (Basel)       Date:  2022-05-18       Impact factor: 3.847

Review 3.  Dermatomyositis autoantibodies: how can we maximize utility?

Authors:  Luqman Mushila Hodgkinson; Tiffany Tingshuen Wu; David Franklin Fiorentino
Journal:  Ann Transl Med       Date:  2021-03

Review 4.  The Role of Myositis-Specific Autoantibodies in the Dermatomyositis Spectrum.

Authors:  Harshita Marasandra Ramesh; Sai Sreeya Gude; Shravya Venugopal; Nikhil Chowdary Peddi; Sai Sravya Gude; Sravya Vuppalapati
Journal:  Cureus       Date:  2022-03-08

Review 5.  Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis.

Authors:  Milena Marzęcka; Anna Niemczyk; Lidia Rudnicka
Journal:  Clin Rev Allergy Immunol       Date:  2022-02-11       Impact factor: 10.817

Review 6.  Advancements in the Treatment of Cutaneous Lupus Erythematosus and Dermatomyositis: A Review of the Literature.

Authors:  Kareem G Elhage; Raymond Zhao; Mio Nakamura
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-08

Review 7.  Off-Label Uses of Rituximab in Dermatology.

Authors:  Connor Cole; Kyle T Amber
Journal:  Curr Dermatol Rep       Date:  2022-10-06

Review 8.  Determination of Folic Acid Using Biosensors-A Short Review of Recent Progress.

Authors:  Alessio Di Tinno; Rocco Cancelliere; Laura Micheli
Journal:  Sensors (Basel)       Date:  2021-05-12       Impact factor: 3.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.